MicroPort Scientific Corporation

DB:MSK Stock Report

Market Cap: €1.4b

MicroPort Scientific Past Earnings Performance

Past criteria checks 0/6

MicroPort Scientific's earnings have been declining at an average annual rate of -41.6%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 7% per year.

Key information

-41.6%

Earnings growth rate

-41.2%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate7.0%
Return on equity-41.6%
Net Margin-40.1%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How MicroPort Scientific makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:MSK Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 241,027-412511307
31 Mar 24989-445524343
31 Dec 23951-478537379
30 Sep 23935-439549400
30 Jun 23918-401562421
31 Mar 23880-419569420
31 Dec 22841-437576420
30 Sep 22820-410585393
30 Jun 22799-384594367
31 Mar 22789-330571332
31 Dec 21779-276548298
30 Sep 21753-246501267
30 Jun 21726-216455237
31 Mar 21688-204440215
31 Dec 20649-191424193
30 Sep 20678-138418174
30 Jun 20708-85413156
31 Mar 20751-19404154
31 Dec 1979346395151
30 Sep 1977356379141
30 Jun 1975266364131
31 Mar 1971145339118
31 Dec 1866924314105
30 Sep 186032327990
30 Jun 185372124474
31 Mar 184902022466
31 Dec 174441920558
30 Sep 174262519956
30 Jun 174093119453
31 Mar 173992219353
31 Dec 163901419352
30 Sep 16387519556
30 Jun 16383-419660
31 Mar 16379-819560
31 Dec 15376-1219360
30 Sep 15369-3219658
30 Jun 15363-5219856
31 Mar 15359-5620156
31 Dec 14355-5920455
30 Sep 14312-3016347
30 Jun 14268-112238
31 Mar 14210128434
31 Dec 13152244529

Quality Earnings: MSK is currently unprofitable.

Growing Profit Margin: MSK is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: MSK is unprofitable, and losses have increased over the past 5 years at a rate of 41.6% per year.

Accelerating Growth: Unable to compare MSK's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MSK is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (21%).


Return on Equity

High ROE: MSK has a negative Return on Equity (-41.61%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies